Sagar Lonial serves as Executive at TG THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Sagar Lonial has executed 10 insider transactions totaling $2.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 11, 2025 involved selling 20,852 shares valued at $672.3K.
Sagar Lonial currently holds 94,061 shares of TG THERAPEUTICS, INC. (TGTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sagar Lonial has been a net seller of TGTX stock. They have purchased $0 and sold $2.0M worth of shares.
Sagar Lonial's most recent insider trade was on Sep 11, 2025, when they sold 20,852 shares at $32.24 per share.
Get notified when new Form 4 filings are submitted
| $16.87 |
| Discretionary |
| Jun 19, 2024 | TGTX | $0 | Award | 22,250 | $N/A | Discretionary |
| Jun 17, 2024 | TGTX | $157.1K | Sale | 9,585 | $16.39 | Discretionary |
| Mar 13, 2024 | TGTX | $79.7K | Sale | 5,000 | $15.94 | Discretionary |
| Sep 28, 2023 | TGTX | $0 | Award | 20,000 | $N/A | Discretionary |
| Jun 23, 2023 | TGTX | $814.5K | Sale | 34,854 | $23.37 | Discretionary |
| Jul 20, 2022 | TGTX | $0 | Award | 43,732 | $N/A | Discretionary |
| Jun 18, 2021 | TGTX | $0 | Award | 20,000 | $N/A | Discretionary |
| Jun 22, 2020 | TGTX | $0 | Award | 65,000 | $N/A | Discretionary |